Endoscopic sinus surgery most cost-effective treatment for chronic rhinosinusitis

Does bevacizumab delivered as a submucosal and topical intranasal therapy effectively control hereditary hemorrhagic telangiectasia (HHT)-associated epistaxis?
How much is lost in annual productivity costs for a patient with refractory chronic rhinosinusitis (RCRS), and what is the relationship between productivity costs and RCRS-specific characteristics?
Evidence suggests admitting most patients to otolaryngology ward with continuous pulse oximetry
Could a nasal spray of engineered proteins be used as front-line prophylactic defense against the influenza infection and provide a new way to prevent infection of current and emerging influenza […]
Do patients with chronic rhinosinusitis (CRS), with and without a migraine history, experience comparable quality-of-life (QOL) improvement after endoscopic sinus surgery (ESS)?
What characteristics and disparities are associated with pediatric acute bacterial sinusitis (ABS) complications?
Can the use of steroid eluting stents play a positive role in treating post-surgery recurrent nasal polyposis in the clinic?
Is sinus surgery successful in providing relief and reducing cost?
Endoscopic DCR without stenting reduces intensity of post-operative management, avoids potential for stent-related complications, and offers comparable patient outcomes